[Melkersson-Rosenthal syndrome. Oligosymptomatic form developed during medical treatment of a phobic depressive process].
An oligosymptomatic form of Melkersson-Rosenthal syndrome which developed following psychiatric treatment for depressive phobic disease is presented. Morphological characteristics found in gingival mucosa biopsy are commented on, as well as the evolutive course and therapeutic procedures carried out on the patient.
Bagan Sebastian
J V
JV
Escuela de Estomatología, Facultad de Medicina de Valencia.
Milian Masanet
M A
MA
Orit
M
M
Vera Sempere
F
F
Moragón
M
M
D000328:Adult; D001623:Betamethasone / Q000627:therapeutic use; D002491:Central Nervous System Agents / Q000009:adverse effects; D002492:Central Nervous System Depressants / Q000009:adverse effects; D002908:Chronic Disease; D003131:Combined Modality Therapy; D003866:Depressive Disorder / Q000188:drug therapy; D006099:Granuloma / Q000209:etiology* / Q000473:pathology; D006801:Humans; D008297:Male; D008556:Melkersson-Rosenthal Syndrome / Q000209:etiology* / Q000473:pathology; D010698:Phobic Disorders / Q000188:drug therapy
D002491:Central Nervous System Agents; D002492:Central Nervous System Depressants; D001623:Betamethasone
Síndrome de Melkersson-Rosenthal. Forma oligosintomática desencadenada durante el tratamiento médico de un proceso depresivo fóbico.